Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2013
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms NEXT
- Sponsors Abbott Laboratories
- 31 Aug 2018 Biomarkers information updated
- 14 Mar 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 23 Apr 2008 New trial record.